# Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb Ischemia

> **NCT04255004** · NA · COMPLETED · sponsor: **Ospedale San Donato** · enrollment: 76 (actual)

## Conditions studied

- Critical Limb Ischemia
- Diabetic Foot

## Interventions

- **DEVICE:** Pall Celeris System, point of care device for human cell therapy

## Key facts

- **NCT ID:** NCT04255004
- **Lead sponsor:** Ospedale San Donato
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2019-02
- **Final completion:** 2019-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04255004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04255004, "Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb Ischemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04255004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*